Evidence map›Paper›PMID 26451307›Full record

ArticleOncoimmunology2015

IL-1βR-dependent priming of antitumor CD4

Sabine Kuhn, Jianping Yang, Evelyn J Hyde, Jacquie L Harper, Joanna R Kirman, Franca Ronchese

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sabine KuhnMalaghan Institute of Medical Research ; Wellington, New Zealand ; Victoria University of Wellington ; Wellington, New Zealand.
Jianping YangMalaghan Institute of Medical Research ; Wellington, New Zealand.
Evelyn J HydeMalaghan Institute of Medical Research ; Wellington, New Zealand.
Jacquie L HarperMalaghan Institute of Medical Research ; Wellington, New Zealand.
Joanna R KirmanMalaghan Institute of Medical Research ; Wellington, New Zealand ; Current address: Department of Microbiology; University of Otago ; Dunedin, New Zealand.
Franca RoncheseMalaghan Institute of Medical Research ; Wellington, New Zealand.
Malaghan Institute of Medical Research · NZUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Local immune-activating therapies seek to improve the presentation of tumor antigen, thereby promoting the activation of antitumor CD8

Indexed as

CD4+ T cellsIL-1βmonosodium urate crystalsmycobacteriaPD-1poly I:Cregulatory T cellstumor immunotherapy

Identifiers

PMID26451307
PMCPMC4589042
OpenAlexW1906011822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.